04/23/2024 4:16 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024 4:29 PM | Recursion Pharmaceuticals (Filer)
| Form ARS | |
04/18/2024 4:12 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/18/2024 4:12 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:18 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024 3:55 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144/A | |
04/16/2024 3:15 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
04/16/2024 7:04 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 4:44 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 10:13 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024 9:39 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024 4:42 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 4:42 PM | Burrell Terry-Ann (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 4:43 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 4:43 PM | CHAVEZ R. MARTIN (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 4:43 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 10:09 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024 4:01 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024 5:40 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:43 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024 5:39 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 4:38 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:35 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024 3:35 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024 6:28 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:48 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024 3:32 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 6:08 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 5:53 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:39 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 3:59 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 7:25 AM | Recursion Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/23/2024 6:22 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 5:13 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 4:37 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 3:29 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 6:57 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 6:58 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 6:59 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:00 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:55 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold. |
02/13/2024 6:00 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 6:01 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 6:03 PM | Mauro David J (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 11:21 AM | ARK Investment Management LLC (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024 4:34 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 8:49 AM | FMR LLC (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G | |
02/08/2024 5:54 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:40 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/29/2024 5:52 PM | Larson Tina Marriott (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/29/2024 3:00 PM | ARK Investment Management LLC (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G | |
01/25/2024 5:13 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 9:13 AM | Recursion Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024 3:20 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 5:37 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 5:39 PM | Recursion Pharmaceuticals (Issuer) Virani Shafique (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:34 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 8:55 AM | Recursion Pharmaceuticals (Subject) Virani Shafique (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024 5:50 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 5:51 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 4:02 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 3:14 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 3:15 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 6:59 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 7:03 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:11 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:11 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:11 PM | CHAVEZ R. MARTIN (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:58 PM | Larson Tina Marriott (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 4:48 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 3:11 PM | Larson Tina Marriott (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023 3:32 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023 7:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/19/2023 6:22 PM | Recursion Pharmaceuticals (Issuer) Virani Shafique (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 5:44 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 11:08 AM | Recursion Pharmaceuticals (Subject) Virani Shafique (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023 7:38 AM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
12/15/2023 7:41 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/14/2023 5:51 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 5:53 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 12:58 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 10:15 AM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 3:24 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 9:46 AM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023 4:22 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 1:57 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/30/2023 4:41 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:25 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023 4:52 PM | Recursion Pharmaceuticals (Issuer) Virani Shafique (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 4:53 PM | Larson Tina Marriott (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
His win rate puts Warren Buffett to shame… (Ad) Not long ago I joined Phil Ash for a private one-on-one interview.
And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015…
Without a single loss. Click here now for the full story. |
11/17/2023 4:50 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 5:54 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 5:55 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 11:28 AM | Larson Tina Marriott (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023 11:41 AM | Recursion Pharmaceuticals (Subject) Virani Shafique (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023 10:12 AM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2023 12:09 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023 7:03 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 7:08 AM | Recursion Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |